date:Jun 01, 2012
ersonal behaviors may modify the effects of dietary intake or supplement use on vascular disease. Then, the duration of follow-up and sample size may also contribute to differences between clinical trials.
Third, trials to date have examined the effects of B vitamin supplementation for secondary prevention only.
Source:Clinical Nutrition
Published online ahead of print, doi: 10.1016/j.clnu.2011.01.003
Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cau